This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
1. Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Garnier S. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine. 2003; 21:3442–3445.
2. Bruggemann H, Baumer S, Fricke WF, et al. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci U S A. 2003; 100:1316–1321.
3. Farrar JJ, Yen LM, Cook T, et al. Tetanus. J Neurol Neurosurg Psychiatry. 2000; 69:292–301.
4. Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed). 1985; 291:648–650.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Stechenberg, B. (2008). Clostridium tetani . In: The Neurological Manifestations of Pediatric Infectious Diseases and Immunodeficiency Syndromes. Infectious Disease™. Humana Press. https://doi.org/10.1007/978-1-59745-391-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-59745-391-2_20
Publisher Name: Humana Press
Print ISBN: 978-1-58829-967-3
Online ISBN: 978-1-59745-391-2
eBook Packages: MedicineMedicine (R0)